Chinese infant formula manufacturer Ausnutria Dairy is to buy a majority stake in Dutch dairy group Hyproca.
Ausnutria said on Friday (3 June) that it acquired a 51% stake in the firm, making it Hyproca’s controlling stockholder.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Chinese group said it will create a research and development base in the Netherlands to help it “lay a foundation for its global market”.
Ausnutria plans to integrate Hyproca’s global fine resources and develop the Dutch firm’s global competitive R&D capabilities, it said. The company also plans to build Hyproca’s processing capacity to provide the Chinese market with “safer and higher-standard infant food”.
Austnutria also plans to develop clinical feed experiments in scientific institutions in the Netherlands and China and develop new products based on “cow and goat milk integration”.
If the transaction is successful, Ausnutria will set up a new subsidiary in Hong Kong that will be responsible for sales operations in Asia, while the company will offer its products globally using Hyproca’s sales channels.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“Holland is traditionally a strong country in the dairy industry,” said Ausnutria CEO Yuanrong Chen.
“Their quality of milk resources and techniques is one of the best in the world. The environment of milk resource is unique and can’t be copied. The M&A with Hyproca makes Ausnutria acquire not only a stable and fine milk resource and production base in Europe, but also experience of pasture, milk resources, R&D, technique and quality system to further enhance operation ability and provide Chinese customers with higher nutritious and purer premium dairy products.”
